Papaloisou introduces Lundbeck’s Selincro
Date: 18 Feb 2015

Selincro (nalmefene) is an opioid receptor antagonist used in the management of alcohol dependence. Selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking risk level, without physical withdrawal symptoms and who do not require immediate detoxification. Selincro is produced by the Danish company H. Lundbeck.

For more information about Selincro please click here.